Massive Bio’s mission? Changing lives for cancer patients. We believe every cancer patient, regardless of circumstances, deserves access to the most advanced treatment options available. We help patients find and enroll into oncology clinical trials that are right for them. Our Artificial Intelligence (AI)-driven platform connects cancer patients and their doctors to bio-pharmaceutical clinical trials. Massive Bio serves nearly two dozen pharmaceutical companies and contract research organizations (CROs) providing patient recruitment, site selection and real-world data services in oncology. Founded in 2015, Massive Bio is headquartered in NYC and is privately funded. We prize self-directed, ambitious, quick thinking mavericks as players on our team. Those not afraid to: fail faster, try new things, confront challenges, communicate and think critically, and above all—ACT. Our team has no time to waste. We are changing lives as we bring all options to oncology patients.